These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 35436520)

  • 1. Targeting nucleic acid-based therapeutics to tumors: Challenges and strategies for polyplexes.
    Vetter VC; Wagner E
    J Control Release; 2022 Jun; 346():110-135. PubMed ID: 35436520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics.
    Xu L; Anchordoquy T
    J Pharm Sci; 2011 Jan; 100(1):38-52. PubMed ID: 20575003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in the development of nucleic acid therapeutics for cancer.
    Kalota A; Shetzline SE; Gewirtz AM
    Cancer Biol Ther; 2004 Jan; 3(1):4-12. PubMed ID: 14726654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The current landscape of nucleic acid therapeutics.
    Kulkarni JA; Witzigmann D; Thomson SB; Chen S; Leavitt BR; Cullis PR; van der Meel R
    Nat Nanotechnol; 2021 Jun; 16(6):630-643. PubMed ID: 34059811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CNS Delivery of Nucleic Acid Therapeutics: Beyond the Blood-Brain Barrier and Towards Specific Cellular Targeting.
    D'Souza A; Nozohouri S; Bleier BS; Amiji MM
    Pharm Res; 2023 Jan; 40(1):77-105. PubMed ID: 36380168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleic acid therapeutics for hematologic malignancies--theoretical considerations.
    Opalinska JB; Kalota A; Chattopadhyaya J; Damha M; Gewirtz AM
    Ann N Y Acad Sci; 2006 Oct; 1082():124-36. PubMed ID: 17145934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges and Opportunities for Nucleic Acid Therapeutics.
    Corey DR; Damha MJ; Manoharan M
    Nucleic Acid Ther; 2022 Feb; 32(1):8-13. PubMed ID: 34931905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introduction and History of the Chemistry of Nucleic Acids Therapeutics.
    Gait MJ; Agrawal S
    Methods Mol Biol; 2022; 2434():3-31. PubMed ID: 35213007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Directing the Way-Receptor and Chemical Targeting Strategies for Nucleic Acid Delivery.
    Steffens RC; Wagner E
    Pharm Res; 2023 Jan; 40(1):47-76. PubMed ID: 36109461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyplex gene delivery modulated by redox potential gradients.
    Soundara Manickam D; Oupický D
    J Drug Target; 2006 Sep; 14(8):519-26. PubMed ID: 17050118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of Bcl-2 as a proxy redox stimulus to enhance activity of non-viral redox-responsive delivery vectors.
    Manickam DS; Hirata A; Putt DA; Lash LH; Hirata F; Oupický D
    Biomaterials; 2008 Jun; 29(17):2680-8. PubMed ID: 18377980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of artificial nucleic acids functionalized for damaged gene diagnosis, gene inhibition and delivery system].
    Nakagawa O
    Yakugaku Zasshi; 2014; 134(12):1319-29. PubMed ID: 25452241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status of nucleic acid therapy and its new progress in cancer treatment.
    Lou W; Zhang L; Wang J
    Int Immunopharmacol; 2024 Dec; 142(Pt B):113157. PubMed ID: 39288629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the Liver with Nucleic Acid Therapeutics for the Treatment of Systemic Diseases of Liver Origin.
    Gogate A; Belcourt J; Shah M; Wang AZ; Frankel A; Kolmel H; Chalon M; Stephen P; Kolli A; Tawfik SM; Jin J; Bahal R; Rasmussen TP; Manautou JE; Zhong XB
    Pharmacol Rev; 2023 Dec; 76(1):49-89. PubMed ID: 37696583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The infinite possibilities of RNA therapeutics.
    Mollocana-Lara EC; Ni M; Agathos SN; Gonzales-Zubiate FA
    J Ind Microbiol Biotechnol; 2021 Dec; 48(9-10):. PubMed ID: 34463324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleic acid-based therapeutics for dermal wound healing.
    Sharma P; Kumar A; Agarwal T; Dey AD; Moghaddam FD; Rahimmanesh I; Ghovvati M; Yousefiasl S; Borzacchiello A; Mohammadi A; Yella VR; Moradi O; Sharifi E
    Int J Biol Macromol; 2022 Nov; 220():920-933. PubMed ID: 35987365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospects for nucleic acid-based therapeutics against hepatitis C virus.
    Lee CH; Kim JH; Lee SW
    World J Gastroenterol; 2013 Dec; 19(47):8949-62. PubMed ID: 24379620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid-based nucleic acid therapeutics with in vivo efficacy.
    Sufian MA; Ilies MA
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023 Mar; 15(2):e1856. PubMed ID: 36180107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Advances and Prospects of Nucleic Acid Therapeutics for Anti-Cancer Therapy.
    Lee M; Lee M; Song Y; Kim S; Park N
    Molecules; 2024 Oct; 29(19):. PubMed ID: 39407665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cationic polymer based nanocarriers for delivery of therapeutic nucleic acids.
    Nimesh S; Gupta N; Chandra R
    J Biomed Nanotechnol; 2011 Aug; 7(4):504-20. PubMed ID: 21870455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.